Christopher D. Barrett

Survival benefit of prehospital TXA in fibrinolytic shutdown: Insights from two prospective trauma trials

BACKGROUND: Fibrinolytic phenotypes have been implicated in postinjury pathophysiology and outcomes. While prehospital tranexamic acid (TXA) administration has demonstrated survival benefits, the interaction between TXA administration and distinct fibrinolytic profiles remains po...